J B Marriott
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 11
-
- Protein Degradation and Inhibitors 4
- Cancer therapeutics and mechanisms 3
- Co-authors
- Angus Dalgleish (20 shared papers)George W. Muller (8 shared papers)Keith Dredge (7 shared papers)David Stirling (7 shared papers)Sharon Cookson (6 shared papers)Michael Westby (3 shared papers)Ian Clarke (3 shared papers)Mary Guckian (3 shared papers)
- Journals
- Clinical & Experimental Immunology (7 papers)The Journal of Immunology (2 papers)British Journal of Cancer (2 papers)Expert Opinion on Biological Therapy (2 papers)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United KingdomSwitzerlandItaly
In The Last Decade
J B Marriott
25 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 84
- Hematology 578
- Immunology 318
- Virology 67
- Oncology 303
- Genetics 118
Countries citing papers authored by J B Marriott
This map shows the geographic impact of J B Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J B Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J B Marriott more than expected).
Fields of papers citing papers by J B Marriott
This network shows the impact of papers produced by J B Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J B Marriott. The network helps show where J B Marriott may publish in the future.
Co-authors
The 25 scholars most cited alongside J B Marriott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 261 | |
| 2 | 2002 | 144 | |
| 3 | 2002 | 132 | |
| 4 | 1999 | 107 | |
| 5 | CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. | 1998 | 86 |
| 6 | 2000 | 85 | |
| 7 | 1998 | 74 | |
| 8 | 1996 | 70 | |
| 9 | 1998 | 50 | |
| 10 | 2001 | 46 | |
| 11 | A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. | 2003 | 45 |
| 12 | 2002 | 42 | |
| 13 | 1997 | 42 | |
| 14 | 2003 | 39 | |
| 15 | 1998 | 21 | |
| 16 | 2000 | 21 | |
| 17 | 2001 | 17 | |
| 18 | 2002 | 16 | |
| 19 | 1999 | 15 | |
| 20 | Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine. | 1996 | 11 |
About J B Marriott
J B Marriott is a scholar working on Hematology, Molecular Biology, Immunology, Oncology and Virology, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (4 papers), Immunotherapy and Immune Responses (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), HIV Research and Treatment (4 papers), Research on Leishmaniasis Studies (3 papers), Immune Cell Function and Interaction (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Hematology (578 citations), Immunology (318 citations), Virology (67 citations), Oncology (303 citations) and Genetics (118 citations). J B Marriott has collaborated with scholars based in United Kingdom, Switzerland and Italy. Frequent co-authors include Angus Dalgleish, George W. Muller, Keith Dredge, David Stirling, Sharon Cookson, Michael Westby, Ian Clarke, Mary Guckian, Roger Chen and Stephen Todryk. Their work appears in journals such as Clinical & Experimental Immunology, The Journal of Immunology, British Journal of Cancer, Expert Opinion on Biological Therapy and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.